632 related articles for article (PubMed ID: 8645771)
1. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
2. [Long-term clinical experience with clozapine].
Gelly F; Chambon O; Marie-Cardine M
Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
[TBL] [Abstract][Full Text] [Related]
3. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
Stengler-Wenzke K
Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
[TBL] [Abstract][Full Text] [Related]
5. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
Freudenreich O; Weiner RD; McEvoy JP
Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
[TBL] [Abstract][Full Text] [Related]
6. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
Henderson DC; Goff DC
J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
[TBL] [Abstract][Full Text] [Related]
7. [Schizophrenia, affective symptoms and clozapine].
Meynard JA; Bernadet R; Sanchez MF; Morel P
Encephale; 1995 Jun; 21 Spec No 3():41-7. PubMed ID: 7628341
[TBL] [Abstract][Full Text] [Related]
8. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
9. [Quality of life of schizophrenic patients and clozapine].
Raoul Y; Manesse P; Delage M
Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
[TBL] [Abstract][Full Text] [Related]
10. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
Schulz E; Remschmidt H; Fleischhaker C
Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324
[TBL] [Abstract][Full Text] [Related]
11. [Importance of determining clozapine plasma level in follow-up of schizophrenic patients].
Vailleau JL; Jeanny B; Chomard P; Vincent R
Encephale; 1996; 22(2):103-9. PubMed ID: 8706619
[TBL] [Abstract][Full Text] [Related]
12. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
Mattes JA
J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
[TBL] [Abstract][Full Text] [Related]
13. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
14. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
15. New developments in the pharmacological treatment of schizophrenia.
Kane JM
Bull Menninger Clin; 1992; 56(1):62-75. PubMed ID: 1348197
[TBL] [Abstract][Full Text] [Related]
16. [Treatment refractory schizophrenia].
Vanelle JM
Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336
[TBL] [Abstract][Full Text] [Related]
17. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
[TBL] [Abstract][Full Text] [Related]
18. Early developmental differences between DSM-III-R schizophrenics treated with clozapine and typical neuroleptics.
Mäkikyrö T; Leinonen E; Koponen H; Järvelin MR; Hakko H; Saarnisaari O; Isohanni M
J Psychiatr Res; 1998; 32(2):105-10. PubMed ID: 9694006
[TBL] [Abstract][Full Text] [Related]
19. [Neuroleptic modification of basic schizophrenic disorders].
Heim M; Morgner J
Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
[TBL] [Abstract][Full Text] [Related]
20. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
